Sergei A. Tjulandin
Moscow, MOW 115522, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Mutations in Mismatch Repair Genes and Microsatellite Instability Status in Pancreatic Cancer.
Journal: Cancers
Published: March 25, 2024
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 16, 2024
Prognostic and predictive role of immune microenvironment in colorectal cancer.
Journal: World journal of gastrointestinal oncology
Published: November 23, 2023
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 01, 2023
A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer.
Journal: Investigational new drugs
Published: January 24, 2023
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Journal: The Lancet. Oncology
Published: November 03, 2022
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 15, 2021
Patterns of Care and Barriers to Utilization of Definitive Concurrent Chemoradiation Therapy for Stage III Non-Small Cell Lung Cancer in Russia.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: January 24, 2021
Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy.
Journal: Cancer biology & therapy
Published: October 07, 2020
Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 22, 2020
Management of Muscle Invasive Bladder Cancer with Bladder Preservation in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: March 05, 2020
Agreement between PDL1 immunohistochemistry assays and polymerase chain reaction in non-small cell lung cancer: CLOVER comparison study.
Journal: Scientific reports
Published: October 27, 2019
Last Updated: 09/26/2026